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Abstract
Whole exome sequencing provides unprecedented opportunities to identify causative DNA variants in rare Mendelian
disorders. Finding the responsible mutation via traditional methods in families with hearing loss is difficult due to a high
degree of genetic heterogeneity. In this study we combined autozygosity mapping and whole exome sequencing in a
family with 3 affected children having nonsyndromic hearing loss born to consanguineous parents. Two novel missense
homozygous variants, c.508C.A (p.H170N) in GIPC3 and c.1328C.T (p.T443M) in ZNF57, were identified in the same ,6M b
autozygous region on chromosome 19 in affected members of the family. Both variants co-segregated with the phenotype
and were absent in 335 ethnicity-matched controls. Biallelic GIPC3 mutations have recently been reported to cause
autosomal recessive nonsyndromic sensorineural hearing loss. Thus we conclude that the hearing loss in the family
described in this report is caused by a novel missense mutation in GIPC3. Identified variant in GIPC3 had a low read depth,
which was initially filtered out during the analysis leaving ZNF57 as the only potential causative gene. This study highlights
some of the challenges in the analyses of whole exome data in the bid to establish the true causative variant in Mendelian
disease.
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Introduction
Hearing loss is one of the most common sensorial disorders in
humans. Genetic factors account for more than 50% of cases with
congenital or prelingual hearing loss, with autosomal recessive
(77%), autosomal dominant (22%), and X-linked inheritance (1%)
[1,2]. Identification of the responsible mutation in families with
autosomal recessive nonsyndromic hearing loss is difficult since
there are mutations in 40 different genes identified for this
common form of deafness (Hereditary Hearing Loss Home-
page_http://hereditaryhearingloss.org/). A two step approach
combining linkage analysis and whole exome sequencing based
on the next generation technologies have been applied previously
in other studies for Mendelian disease [3,4] including deafness
[5,6]. The first step uses the genome wide SNP genotyping to
identify autozygous regions when parental consanguinity is
present and narrows down the search space for possible loci.
The second step examines exome sequences to identify genetic
variation at base-pair resolution and survey the protein coding
portion of the human genome [7]. The integrated approach is
faster and more cost efficient than the sequencing various
candidate genes with the traditional Sanger sequencing tech-
niques since the resulting loci generated from linkage are typically
too large [3]. Thus whole exome sequencing using the next
generation technologies provides a new and transformational
approach for identifying causative mutations in Mendelian
disorders [5,7–12]. Here, we apply this two step approach, face
the challenges, and eventually uncover a novel mutation causing
hereditary hearing loss in a family. This study provides some
comprehensive insights which would be valuable in certain
scenarios and will help minimize certain limitations in using the
new whole exome sequencing technologies.
Materials and Methods
This study was approved by the Ankara University Medical
School Ethics Committee (Turkey), and by the University of
Miami Institutional Review Board (USA). All participants
provided written informed consent prior to enrollment. Written
informed consent was obtained from the next of kin on the behalf
of the minors/children participants involved in this study. A family
with three affected children who were diagnosed with sensorineu-
ral hearing loss via standard audiometry was recruited (Figures 1A
and 1B). A thorough clinical evaluation including an ophthalmo-
logical exam and high resolution CT scans of the temporal bone in
affected family members were normal. EKGs, liver and kidney
function tests, serum electrolytes, urinalysis, CBC, and leukocyte
subgroups were all within normal limits in affected subjects. DNA
was extracted from peripheral leukocytes of each member of the
family via a phenol chloroform method. Obtained samples were
prescreened for mutations in GJB2 (MIM 121011) via Sanger
sequencing of both exons and for the m.1555A.G mutation in
MTRNR1 (MIM 561000). Heterozygous p.M163V amino acid
change was found in GJB2 in all three affected and three
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were present in the affected members.
Genome-wide SNP genotyping was performed in six members
of the family (III-1, III-2, IV-3, IV-5, IV-6, and IV-7) using
Affymetrix 6.0 arrays. Genotypes were transferred into Excel files
and sorted according to genomic positions along with all 40
previously identified autosomal recessive nonsyndromic deafness
genes. The co-segregation of the flanking genotypes for each gene
was visually evaluated.
In order to identify the responsible variant, genomic DNA of
IV-7 was evaluated by whole exome sequencing. The Agilent
Human SureSelect 50 MB kit was used to extract the target
regions from genomic libraries for exome sequencing. The sample
was multiplexed with two other samples in a single lane of an
Illumina HiSeq 2000 flow cell allowing for the sequencing of
101 bp paired-end reads. Raw data were analyzed using v1.7 of
the Illumina CASAVA pipeline to extract the reads.
The reads were aligned with the human genome reference
sequence (hg19 build), using the Mapping and Assembly with
Quality (MAQ) software v0.7.1 [13]. Pairs of reads with identical
outer coordinates were removed to improve the overall accuracy
of variant calling. Variants (SNPs and indels) were called with
MAQ. SNPs with a read coverage $86 and a Phred-like
consensus quality of $20 were considered in the initial analysis.
SNPs were annotated with SeattleSeq (http://gvs.gs.washington.
edu/SeattleSeqAnnotation/) version 6.13 into functional catego-
ries such as missense, nonsense, splice sites, coding, non-coding,
UTRs. DNA variants were filtered against dbSNP132 [14] and
phase 3 of the 1000 Genomes project. PolyPhen2 predictions were
generated for non-synonymous SNPs [15]. Indels with read
coverage $86covered by reads from both strands were predicted.
Indels were annotated with SeattleSeq with respect to relative
position of a gene (eg coding sequence, downstream or intronic)
and their affects (eg frame-shift, amino-acid insertion or amino-
acid deletion). After the initial analysis SNPs and indels were re-
analyzed with read coverage $26and $46for comparison of the
obtained variants.
The Agilent Human SureSelect 50 MB whole exome capture
and subsequent sequencing was evaluated by calculating the
fraction of the target covered and the average read depth of the
target. The MAQ alignments formed the basis of the depth and
coverage calculations (Figures 2 A and 2B). On-target and off-
target coverage were computed to create wig files that are
uploaded into the UCSC Genome Browser [16] for visual
Figure 1. Pedigree with haplotypes, audiograms and two identified variants. (A) The pedigree and the third longest autozygous region on
chromosome 19 that co-segregates with the phenotype. (B) Audiograms of affected members in the family. (C) Electropherograms showing the wild
type, homozygous and heterozygous forms of the variant p.T443M in ZNF57. (D) Electropherograms showing the wild type, homozygous and
heterozygous form of the variant p.H170N in GIPC3.
doi:10.1371/journal.pone.0032000.g001
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interest (Figures 2C and S1).
Three-dimensional models were built using MODELER [17]
from the Accelrys Discovery Studio package. BLAST sequence
similarity searches [18] were used to identify suitable structural
templates. This was done by using the query sequence and
searching against the database of sequences from the Protein Data
Bank (PDB) [19] using BLAST. The structural templates were
selected by choosing the sequence of known structure with the
highest percent identity with the query sequence. Software
modules from the Accelrys Discovery Studio were used to inspect
the molecules for quality control and to create illustrations.
Results
Results of genome-wide SNP genotyping showed that none of
the known deafness genes co-segregated with the phenotype. In
the family, five autozygous segments longer than 2 Mb were
present on chromosomes 8, 15, 16, 19 and 21 (Table 1). These five
autozygous regions include 382 annotated genes.
The exome sequencing experiment of one affected individual
(IV-7) achieved the expected number of reads (87,586,240) and
target coverage plus average read depth. Eighty seven million
reads were generated which constitutes 8.6 gigabases of raw
sequence. More than 95% of the reads mapped to the reference
genome. Comparable with other labs [5,9–11,20,21], when
measured at a minimum depth of 86, 82% of the target region
was covered with an average depth of 686(Figure 2A). Likewise,
when measured at 16and 206coverage, nearly 95% and 69% of
the intended target was covered with an average depth of 686and
666 respectively. In terms of variant calls, the MAQ predicted
99,374 SNPs and 5,420 indels.
The five autozygous regions from genome wide genotyping data
on chromosomes 8, 15, 16, 19 and 21 were investigated using the
Figure 2. Coverage of autozygous regions with whole exome sequencing. (A) The exome coverage of the five longest autozygous regions.
The plot shows the fraction of on-target coverage (Y-axis) and the read depth (X-axis) for the following specified regions. (B) Average coverage at
minimum 86and GC content of five autozygous regions. (C) Coverage of exon 3 in GIPC3. Red arrow indicates mutation point.
doi:10.1371/journal.pone.0032000.g002
Table 1. Five autozygous regions detected with Affymetrix 6.0 arrays in the family.
Chromosome Start Point (SNP) End Point (SNP)
Autozygous Regions
(hg19)with Affy 6.0
(6 family members) Size (bp)
Autozygous Regions
(hg19) with exome
sequencing in IV:7* Size (bp)
15 rs16952059 rs12593367 68,718,000–81,335,100 12,617,101 74,364,703–81,410,488 7,045,785
8 rs2981099 rs7836491 73,855,527–80,351,787 6,496,261 71,040,655–86048011 15,007,356
19 rs8102615 rs7247153 1–6,451,433 6,451,433 105,101–4,511,278 4,406,177
21 rs11702247 rs2205081 38,699,159–41,708,994 3,009,835 38,568,308–45,651,413 7,083,105
16 rs9926500 rs4782341 85,880,671–88,649,755 2,739,084 85848265–89178474 3,330,209
To define autozygous regions from the exome sequences (*) the following filters were applied to reduce the incident of false positives (phred-like consensus score $100
and a minimum read depth of 20).
doi:10.1371/journal.pone.0032000.t001
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much variation on the read depth was observed. Using a minimum
depth of 8 as a filter, the chromosome 8 region has high average
read depth of 1016 with 92% coverage compared to the
chromosome 19 region which has low average read depth of
156with 38% coverage (Figure 2A). There was a strong negative
correlation (r=20.96) between the percentage of gunanine
cytosine (GC) bases and the read depth or coverage of autozygous
regions (Figure 2B). We focused on exonic and flanking intronic
variants within these five autozygous regions. Table 2 shows the
four novel homozygous missense, nonsense, splice site and frame
shift variants (not reported in dbSNP132) in the five autozygous
regions when we used a filter of minimum 86read depth. Sanger
sequencing confirmed one novel missense variant in the second
longest autozygous region on chr8 (76476256A.T) in HNF4G
(MIM 605966) and one novel missense variant in the third longest
autozygous region on chr19 (2917947C.T) in ZNF57 (no MIM
number available) (nucelotide numbers are according to Hg19).
We then recruited additional family members who were not typed
with Affymetrix 6.0 chips to evaluate co-segregation of these
variants. The novel variant c.1263A.T (p.Q421H) in HNF4G did
not co-segregate with the phenotype in the entire family but
variant c.1328C.T (p.T443M) in ZNF57 did (Figure 1A and C).
For the variant in ZNF57 PolyPhen2 classification was possibly
damaging with a score of 0.938, MutPred predicted that T443M
amino acid substitution caused a gain of catalytic residue at V439
(p=0.0472) and predicted the g score (probability of deleterious
mutation) of 0.497 [15,22]. Four coding exons and intron-exon
boundaries of ZNF57 were Sanger sequenced and no other
nucleotide change was found. The indentified nucleotide change
was not found in 335 Turkish controls via Sanger sequencing.
ZNF57 is a recently discovered human zinc finger gene which
has not been implicated in hearing loss. The ZNF57 protein
product comprises 555 amino-acids with a KRAB-A domain at
the amino-terminus and 13 tandemly arranged C2H2 zinc fingers
at the carboxyl-terminus. Over expression of ZNF57 was shown to
inhibit the transcriptional activities of NFAT and p21 demon-
strating that ZNF57 is likely to function as a negative
transcriptional regulator in NFAT-p21 signaling pathway [23].
The variant p.T443M is located in the linker between zinc fingers
10 and 11. The wild type linker in ZNF57 (has the sequence
TQEQL) and the canonical zinc finger linker sequence is
TGEKP. Both linkers comprise five residues and have a conserved
threonine at the first position. Threonine at this position is highly
conserved and attains a ConSeq conservation score of 8 in a scale
of 1 to 9 (where 9 is most conserved) [24]. This conserved
threonine is changed to methionine in the variant form of ZNF57
p.T443M. The functional unit for the zinc finger protein ZNF57 is
unknown. Whilst zinc fingers are known to bind DNA, zinc fingers
also interact directly with proteins [25] and RNA [26] and many
have more than one role and form both protein-DNA and protein-
protein interactions [25–29].
The full-length ZNF57 sequence was BLASTed against the
sequences of the PDB. A designed zinc finger peptide with six zinc
fingers known as Aart [30] had the highest percent sequence
identity with the query. The query sequence ZNF57 (with only the
Table 2. Novel missense, nonsense, splice site, and frameshift variants in top five autozygous regions.
Chromosome
Position
(hg19)
Reference
Base Alleles
Accession
Number
Variant
Category
Amino
Acids
Protein
Position
Gene
List
Phred
Quality
Read
Depth Sanger
8
a 76,476,256 A T/T NM_004133 missense GLN,HIS 421/446 HNF4G 255 118 +
15
a 79,045,519 C T/T XM_929902 missense ARG,CYS 43/86 LOC646938 75 16 2
15
a 75,581,777 C A/A NM_001145224 missense GLN,LYS 202/694 GOLGA6D 22 28 2
19
a 2,917,947 C T/T NM_173480 missense THR,MET 443/556 ZNF57 255 82 +
15 79,058,730 A G/G NM_014272 missense SER,PRO 1175/1687 ADAMTS7 39 4 2
19 3,586,908 C A/A NM_133261 missense HIS,ASN 170/313 GIPC3 42 5 +
aThese variants were detected when filter for read depth was $86.
doi:10.1371/journal.pone.0032000.t002
Figure 3. Molecular modeling of p.T443M in ZNF57. The zinc finger domain comprises two b-strands (blue) and one a-helix (red); the turns
(green) and the loops (light gray) are shown. Amino-acid residue 443 is pink in the wild type (A) and yellow in the mutant (B).
doi:10.1371/journal.pone.0032000.g003
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template Aart (PDB Code: 2I13 – chain B) using the Accelrys
global alignment program. The alignment comprises 144
topologically equivalent position sharing 47.2% sequence identity
(ZNF57:362–505 and 2I13:152–295). Indels were absent in the
alignment. Protein structural models for ZNF57 (the wild type and
p.T443M) were built (Figure 3). Threonine 443 of the wild type is
the last residue at the C-terminal end of the a-helix and likely
contributes to the a-helix cap (Figure 3). The methionine side
chain is longer, more flexible and is unbranched compared with
threonine (Figure 3). Mutation of threonine to methionine is likely
to affect DNA binding capability indirectly in several different
ways [31,32]. Threonine is capable of being phosphorylated
whereas methionine is not. Phosphorylation and dephosphoryla-
tion is implicated in the regulation of zinc finger protein binding
and function and the conserved threonine in the linker region is a
prime candidate for this type of regulation. Threonine is on the
surface and accessible to possible phosphorylation events [31].
Others suggest that the DNA-induced helix capping in the
conserved linker sequence is a determinant of binding affinity in
C2H2 zinc fingers [32]. In evolution, threonine is one of the most
frequently observed amino acids at this position in the zinc finger
domain topology [26]. In mutational studies of the linkers between
two contiguous zinc fingers, mutation of threonine to alanine had
deleterious effects on DNA binding [33]. Similarly, mutating
threonine to leucine in the linker was shown to reduce DNA
binding [34].
While this work was ongoing a missense mutation in Gipc3 was
reported to be associated with age-related sensorineural hearing
loss in the mouse, and two missense variants in GIPC3 (MIM
608792) in two small families with sensorineural hearing loss [35].
The autozygous region on chromosome 19 in our family also
includes GIPC3, in which no novel variant had passed our filters.
We then re-analyzed the exome sequencing data reducing the
filter for read depth to $46 instead of $86; two additional
variants in autozygous regions were detected (Table 2) and only
the variant c.508C.A (p.H170N) in exon 3 of GIPC3 was
confirmed by Sanger sequencing (Figure 1D). Read depth for this
variant was 5 and the exon containing this variant was poorly
covered (Figure 2C). PolyPhen2 classification for this variant was
probably damaging (score 1.0) and MutPred predicted the g score
(probability of deleterious mutation) as 0.850. A ConSeq
conservation score of 9 is obtained for H170 showing that this
residue is highly conserved. The mutation was absent in 335
healthy ethnicity-matched controls.
The GIPC3 sequences (wild type and p.H170N) were each
aligned with the PDZ domain in GIPC2 (PDB code: 3GGE -
chain B). The alignment (GIPC3:108–199 and 3GGE:3–95)
comprises 92 positions sharing 26.6% sequence identity with no
indels. The structural template (3GGE) and the models each have
two a-helices and six b-strands. Protein structural models for
GIPC3 (the wild type and p.H170N) were built (Figures 4A and
4B). The mutated form of GIPC3 was compared with the wild
type, structural differences were observed. In the mutated form of
the model, the substrate molecular recognition pocket was larger
and the associated charge distribution was reduced (Figures 4C
and 4D) compared with the wild type. In the wild type H170 side
chain is pointing away from the core and the resulting side chain is
solvent accessible whilst the asparagine side chain 170 in the
mutated form of GIPC3 points inwards towards the hydrophobic
core and forms a tight network of H-bonds. The asparagine side
chain forms two side chain H-bonds with two main chain atoms
(ASP 128 NH: ASN 170 OD1 and ASN 170 OD2-HD22:THR
127 O) which renders the side chain solvent inaccessible. In
addition, N170 forms two main chain to main chain H bonds
(ALA 174: ASN 170 O and VAL 173 N:ASN 170 O). Residue 170
is the first residue of a-helix 2. In the wild type the side chain
solvent accessibility for residue H170 is greater than 10%. H170
does not form side chain to side chain H-bonds within the PDZ
domain (Figures 4E and 4F). Whilst the accepted amino acid
residue substitution profile is variable at position 170 across the
PDZ superfamily [36,37], histidine for the GIPC family members
at this position is invariant. This position 170 coincides with a key
ligand binding pocket [36,37] and the mutation from histidine to
Figure 4. Diagrams of structural models for GIPC3. The ribbon
diagrams for the 3D models of the PDZ domain in GIPC3. The wild type
(A) and the mutated p.H170N (B) forms are shown. The key for
structural features follow; the a-helices (red); the b-strands (blue); the b-
turns (green); the loops (light gray); the side-chain for H170 in the wild
type (pink) and the side-chain for N170 highlights the mutation
(yellow). The surface diagrams show the surface topology and the
interpolated charge distribution of the PDZ domain of GIPC3. Both the
wild type (C) and the mutated p.H170N protein (D) are provided. The
p.H170N mutated form shows one of the substrate molecular
recognition pockets as being deeper with a larger volume compared
to the wild type. The p.H170N mutated form shows the interpolated
charge distribution as being reduced compared with the wild type.
Structural and local environment for position 170 with the H-bond
patterns are shown. The GIPC3 wild type (E) shows an absence of side-
chain to main-chain H-bonds with the H170 side-chain; whilst the
asparagine side-chain (yellow) in the mutated protein (F) forms side-
chain to main-chain H-bonds.
doi:10.1371/journal.pone.0032000.g004
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change of substrate specificity resulting in an adverse alteration in
the protein function.
Discussion
After finding potential regions through autozygosity mapping
we identified two novel rare variants to cause hearing loss in this
study (GIPC3 p.H170N and ZNF57 p.T443M). Both variants
were good candidates based on genetic and in silico data. It is
important to restate that the first analysis was done using
minimum read depth of 86 and the variant in GIPC3 was not
detected until a less stringent filtering was performed. If GIPC3 was
not known as a cause of deafness we could have concluded that the
variant in ZNF57 was causative. Human GIPC3 gene encodes a
312 amino acid protein which localizes to the sensory hair cells in
the inner ear [35]. In addition to the central PDZ domain, there
are two conserved domains as GIPC homologous domain 1 (GH1
domain) and GH2 domain. The GH2 domain of GIPC1 interacts
directly with the actin-based molecular motor myosin VI, in which
mutations cause hearing loss in humans and mice [38–40]. After
two missense mutations reported in one Indian and one Dutch
family in GIPC3 [35], very recently six more missense and a
nonsense mutations were described in seven Pakistani families [41]
(Figure 5). Following the previously reported p.R189C mutation in
a Pakistani family, the p.H170N mutation in the Turkish family
described in this study is the second mutation outside of one of the
two GH domains. We should note that the mutation ZNF57
p.T443M might not be a red herring. We can speculate that this
mutation also may contribute to hearing loss or more likely it
might contribute to the susceptibility for another phenotype which
was not considered here and that these two variants (ZNF57
p.T443M and GIPC3 p.H170N) are found to co-segregate. Whilst
the ZNF57 variant (NC_000019.9:2917947C.T, NM_173480.
2:c.1328C.T, NP_775751.1:p.Thr443Met) is absent in dbSNP
version 132, we note that in a recent update of the dbSNP (version
135), this variant is present as rs142727006 with an allele
frequency of 0.003. The GIPC3 variant (NC_000019.9:3586908)
is absent from both the dbSNP (version 135) and the NHLBI
Sequencing Project/Exome Variant Server Database. Our study
clearly demonstrates some of the challenges faced using the high
throughput exome sequencing technologies to find causative
mutations in Mendelian disease. Table 3 shows the differences
between analyzing the data using coverage filters of 26,4 6and
86. The ultimate goal of this combined approach is to identify
disease causing mutations accurately and economically. To
minimize the number of false negative results, an exome
sequencing experiment requires adequate and uniform sequencing
depth across the target regions. We demonstrate that despite
attaining the expected quality metrics for the number of reads, the
amount of DNA generated, the target coverage and the average
depth across the intended target, a marked unevenness of capture
of one region compared with other regions was evident (Figure 2).
The targeted regions were not captured with uniformity (Figure
S1) and we present this as an issue which needs to be evaluated
with care when using exome sequencing as a tool for Mendelian
disease gene discovery. Several factors can influence uniformity
and unbiased capture and these include biases in the GC content
as we clearly illustrate in this study (Figure 2). This study has
provided some comprehensive insights and will be informative for
scientists who plan to use exome sequencing technology. In certain
scenarios this information may influence analysis or experimental
design to reduce some of the limitations in surveying exome
sequences for Mendelian disease gene discovery.
Figure 5. The two-dimensional structure of GIPC3 and the localization of identified mutations.
doi:10.1371/journal.pone.0032000.g005
Table 3. Number of variants (SNPs) compared to the reference genome (hg19) with differing minimum depth filter and
annotation categories.
Filter Parameters Whole Exome Chr19:1-6,451,433
Minimum depth filter 26 46 86 26 46 86
Total variants 505,714 165,717 99,374 1,324 559 282
Novel variants (Not reported in dbSNP132) 244,726 61,182 24,594 730 287 119
Novel missense, nonsense, splice site variants 7,204 6,056 4,472 97 66 35
Novel homozygous Variants 3,644 149 108 5 2 1
doi:10.1371/journal.pone.0032000.t003
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Figure S1 Coverage and read depth of five autozygous
regions.
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